The best way to illustrate the efficacy of the SBAR (Subject, Background, Assessment, and Recommendation) framework is to examine its application to a frequently seen condition: non-valvular atrial fibrillation. This type of arrhythmia increases the risk of stroke and can be treated by the administration of anticoagulants. But patients who are at risk for bleeding are not suitable candidates for this treatment.
One alternative is the implantation of a device that removes the left atrial appendage — a common site for the formation of clots — from blood circulation. This entails a thorough clinical assessment followed by rigorous preoperative and postoperative management of the patient and participation in a registry to track patient outcomes. In addition, the hospital must weigh factors such as whether it possesses the necessary facilities and staff to properly support the patient.
Download the Comprehensive Safe Start white paper written by TractManager’s value analysis experts, Dee Donatelli, Dr. Mark Kestner, Dr. Kristin Stitt, and Barry Dyer, and learn how to:
- Better assess the clinical, infrastructural, and financial impact of a technology.
- Foster more inclusive and effective value analysis decisions.
- Achieve measurable improvements in Quadruple Aim performance indicators.